Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Cardinal Health Inc
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Wholesale-Drugs, Proprietaries & Druggists' Sundries
No intraday reading yet this session.
Each disclosed tie as a share of both companies’ annual revenue. The bigger share is the side that would feel it if the relationship ended.
| Partner | % of their revenue | % of CAH revenue | Skew |
|---|---|---|---|
| CVSCVS Health Corporation | 18.97% | 30.00% | 1.6× |
| GILDGilead Sciences, Inc. | 26.00% | 3.01% | 8.6× |
| PCRXPacira BioSciences, Inc. | 26.00% | 0.07% | 350× |
| SUPNSupernus Pharmaceuticals, Inc. | 20.00% | 0.06% | 354× |
| EMBCEmbecta Corp. | 14.00% | 0.06% | 235× |
| VTRSViatris Inc | 5.00% | 0.28% | 18× |
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“Our largest customer, CVS Health, accounted for 30 percent of our fiscal 2025 revenue.”
$76.3B relationship1.6× more of CAH’s book than CVS’s
basisCAH fy2026 · closed 2026-06 $254BCVS fy2025 · closed 2025-12 $402B
The two fiscal years close in different months, so the derived share compares periods that do not line up exactly.
FILING10-K0000721371-25-000079cik 0000721371
“In fiscal 2024, both CVS Health and OptumRx individually accounted for at least 10 percent of revenue and/or gross trade receivables.”
$43.2B relationship
basisCAH fy2026 · closed 2026-06 $254B
FILING10-K0000721371-25-000079
“Sales to members of these two GPOs, under numerous contracts across our businesses, collectively accounted for 27 percent of our revenue in fiscal 2025.”
$34.3B relationship
basisCAH fy2026 · closed 2026-06 $254B
FILING10-K0000721371-25-000079
“Sales to members of these two GPOs, under numerous contracts across our businesses, collectively accounted for 27 percent of our revenue in fiscal 2025.”
$34.3B relationship
basisCAH fy2026 · closed 2026-06 $254B
FILING10-K0000721371-25-000079
“In 2025, three wholesale distributors (McKesson Corporation, Cardinal Health, Inc. and Cencora, Inc.) accounted for substantially all of AbbVie's pharmaceutical product sales in the United States.”
FILING10-K0001551152-26-000008cik 0001551152disclosed by ABBV
“We conduct business with the three major wholesalers in the U.S.: Cencora, Inc., Cardinal Health, and McKesson.”
FILING10-K0001023024-26-000014cik 0001023024disclosed by ANIP
“VWR International, LLC, Cardinal Health, Inc. and Medline Industries Inc. are also distributors of our products.”
FILING10-K0001437749-26-007797cik 0000884269disclosed by APT
“For example, for the fiscal year ended September 30, 2025, gross sales to Cencora, McKesson Corporation, and Cardinal Health, Embecta's three largest distributors, together represented approximately 42% of Embecta's worldwide gross sales.”
$151M relationship235× more of EMBC’s book than CAH’s
basisEMBC fy2025 · closed 2025-09 $1.1BCAH fy2026 · closed 2026-06 $254B
The two fiscal years close in different months, so the derived share compares periods that do not line up exactly.
“Cardinal Health, Inc. 26 % 26 % 25 %”
$7.7B relationship8.6× more of GILD’s book than CAH’s
basisGILD fy2025 · closed 2025-12 $29.4BCAH fy2026 · closed 2026-06 $254B
The two fiscal years close in different months, so the derived share compares periods that do not line up exactly.
“In 2025, 2024, and 2023, three wholesale distributors in the U.S.—McKesson Corporation, Cencora, Inc., and Cardinal Health, Inc.—each accounted for a significant percentage of our consolidated revenue.”
FILING10-K0000059478-26-000013cik 0000059478disclosed by LLY
“Our specialty distributor network sells to hospitals, physician practices and other sites of care and consists of McKesson, ASD/Oncology Supply, Cardinal Health, DMS Pharmaceutical Group and Bio Care.”
FILING10-K0001437749-26-005891cik 0001401667disclosed by PBYI
“We had three wholesalers each comprising 10 percent or more of our total revenue for the year ended December 31, 2025: McKesson Drug Company, Cardinal Health, Inc. and AmerisourceBergen Health Corporation, which accounted for 31%, 26% and 22% of our total revenues, respectively.”
$189M relationship350× more of PCRX’s book than CAH’s
basisPCRX fy2025 · closed 2025-12 $726MCAH fy2026 · closed 2026-06 $254B
“Each of our three major customers, Cencora, Inc., Cardinal Health, Inc., and McKesson Corporation, individually accounted for more than 20% of our total product revenue in 2024 and collectively accounted for more than 77% of our total product revenue in 2024.”
$144M relationship354× more of SUPN’s book than CAH’s
basisSUPN fy2025 · closed 2025-12 $719MCAH fy2026 · closed 2026-06 $254B
“Cardinal Health, Inc. * 5 % 5 %”
$715M relationship18× more of VTRS’s book than CAH’s
basisVTRS fy2025 · closed 2025-12 $14.3BCAH fy2026 · closed 2026-06 $254B
The two fiscal years close in different months, so the derived share compares periods that do not line up exactly.
“In 2025, Cardinal Health Specialty Solutions exclusively handled our U.S. product logistics activities, including warehousing, shipping, and various other customer activities.”
FILING10-K0001087294-26-000020cik 0001087294disclosed by CPIX
“We have also engaged Cardinal Health, Inc., as the exclusive third-party logistics distribution agent for commercial sales of Auryxia and Vafseo.”
FILING10-K0001517022-26-000020cik 0001517022disclosed by AKBA
“LYMPHIR, Citius Oncology has entered into distribution agreements with Cardinal Health, Cencora and McKesson Corporation.”
FILING10-K0001213900-25-125333cik 0001506251disclosed by CTXR
“In the United States, third parties, such as Cardinal Health, Inc. and Medline Inc., warehouse and ship a significant portion of our products through their distribution centers.”
FILING10-K0001628280-26-007733cik 0000010456disclosed by BAX
“Our primary wholesale distributor relationships currently include Cardinal Health, Inc., McKesson Corporation, Smith Drug Company, and Morris and Dickson Co. L.L.C., in addition to various generic drug manufacturers.”
FILING10-K0001193125-26-102172cik 0001802255disclosed by GRDN
“Cardinal Health, Inc. is our third-party logistics provider and manages reverse distribution, pharmaceutical returns and product recall, if needed.”
FILING10-K0001104659-26-018859cik 0001802665disclosed by HRMY
Watchlist prices, news filtered to it, and its next report on your desk.
FILING10-K0001872789-25-000036cik 0001872789disclosed by EMBC
The two fiscal years close in different months, so the derived share compares periods that do not line up exactly.
FILING10-K0001628280-26-012297cik 0001396814disclosed by PCRX
The two fiscal years close in different months, so the derived share compares periods that do not line up exactly.
FILING10-K0001356576-25-000017cik 0001356576disclosed by SUPN
Cardinal Health Inc has 11 disclosed suppliers and 9 disclosed customers. Each one is named in an SEC filing, either Cardinal Health Inc’s own annual report or the counterparty’s, and carries the sentence that discloses it.
CAH (Cardinal Health Inc) has 11 disclosed suppliers and 9 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: SUPN −1.03%, in healthcare.